Joel Greenblatt Eagle Pharmaceuticals, Inc. Transaction History

Gotham Asset Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$40.32 - $50.97 $201,035 - $254,136	-4,986 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.72 - $51.34 $208,015 - $255,981	4,986 New	4,986 $232,000
Q3 2020 Nov 16, 2020	SELL	$37.02 - $51.28 $196,354 - $271,989	-5,304 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$43.24 - $55.02 $864,627 - $1.1 Million	-19,996 Reduced 79.04%	5,304 $254,000
Q1 2020 May 15, 2020	SELL	$34.37 - $60.07 $388,037 - $678,190	-11,290 Reduced 30.86%	25,300 $1.16 Million
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $335,588 - $397,307	-6,178 Reduced 14.45%	36,590 $2.2 Million
Q3 2019 Nov 14, 2019	BUY	$53.25 - $59.98 $457,204 - $514,988	8,586 Added 25.12%	42,768 $2.42 Million
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $584,955 - $733,547	12,550 Added 58.02%	34,182 $1.9 Million
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $628,843 - $842,904	16,266 Added 303.13%	21,632 $1.09 Million
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $177,614 - $327,610	-4,837 Reduced 47.41%	5,366 $216,000
Q3 2018 Nov 14, 2018	SELL	$66.65 - $83.86 $277,663 - $349,360	-4,166 Reduced 28.99%	10,203 $707,000
Q2 2018 Aug 14, 2018	SELL	$51.25 - $76.62 $137,093 - $204,958	-2,675 Reduced 15.69%	14,369 $1.09 Million
Q1 2018 May 15, 2018	SELL	$52.16 - $66.86 $1.84 Million - $2.35 Million	-35,197 Reduced 67.37%	17,044 $898,000
Q4 2017 Feb 14, 2018	SELL	$49.6 - $60.87 $6.19 Million - $7.6 Million	-124,895 Reduced 70.51%	52,241 $2.79 Million
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $8.26 Million - $10.7 Million	177,136	177,136 $10.6 Million

498K

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $19.4M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.